Compare Stocks: SKYA, CNXU, EMBC, and INFU

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNXU Conexeu Sciences	$8.31 -5.9%	$11.41	$7.10 ▼ $18.79	$222.36M	N/A	105,394 shs	164,802 shs
EMBC Embecta	$3.64 -0.5%	$3.29	$2.77 ▼ $15.55	$215.96M	0.83	1.56 million shs	1.25 million shs
INFU InfuSystem	$9.14 -0.5%	$9.31	$5.43 ▼ $11.04	$184.46M	1.4	166,981 shs	172,806 shs
SKYA SkyAI, Inc. Common Stock	$1.31 -2.2%	$1.26	$0.91 ▼ $18.23	$55.44M	2.1	424,673 shs	80,866 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNXU Conexeu Sciences	+11.91%	-3.50%	-19.14%	+882,999,900.00%	+882,999,900.00%
EMBC Embecta	-0.54%	+12.62%	+12.27%	-60.00%	-64.98%
INFU InfuSystem	-5.84%	+3.37%	-4.77%	-9.28%	+60.95%
SKYA SkyAI, Inc. Common Stock	-2.19%	-6.29%	+20.72%	-24.93%	-73.20%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNXU Conexeu Sciences	$8.31 -5.9%	$11.41	$7.10 ▼ $18.79	$222.36M	N/A	105,394 shs	164,802 shs
EMBC Embecta	$3.64 -0.5%	$3.29	$2.77 ▼ $15.55	$215.96M	0.83	1.56 million shs	1.25 million shs
INFU InfuSystem	$9.14 -0.5%	$9.31	$5.43 ▼ $11.04	$184.46M	1.4	166,981 shs	172,806 shs
SKYA SkyAI, Inc. Common Stock	$1.31 -2.2%	$1.26	$0.91 ▼ $18.23	$55.44M	2.1	424,673 shs	80,866 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNXU Conexeu Sciences	+11.91%	-3.50%	-19.14%	+882,999,900.00%	+882,999,900.00%
EMBC Embecta	-0.54%	+12.62%	+12.27%	-60.00%	-64.98%
INFU InfuSystem	-5.84%	+3.37%	-4.77%	-9.28%	+60.95%
SKYA SkyAI, Inc. Common Stock	-2.19%	-6.29%	+20.72%	-24.93%	-73.20%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNXU Conexeu Sciences	2.50	Moderate Buy	$20.00	140.67% Upside
EMBC Embecta	1.60	Reduce	$11.00	202.20% Upside
INFU InfuSystem	2.67	Moderate Buy	$15.00	64.11% Upside
SKYA SkyAI, Inc. Common Stock	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest SKYA, CNXU, EMBC, and INFU Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/17/2026	SKYA SkyAI, Inc. Common Stock	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	EMBC Embecta	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
6/29/2026	CNXU Conexeu Sciences	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
6/22/2026	CNXU Conexeu Sciences	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$20.00
5/18/2026	EMBC Embecta	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Underperform	$11.00 ➝ $3.00
5/8/2026	EMBC Embecta	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
5/6/2026	EMBC Embecta	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)
5/6/2026	EMBC Embecta	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$12.00 ➝ $5.00
5/5/2026	EMBC Embecta	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Neutral

(Data available from 7/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A	N/A
EMBC Embecta	$1.08B	0.20	$3.96 per share	0.92	($11.12) per share	-0.33
INFU InfuSystem	$142.40M	1.30	$0.71 per share	12.79	$2.47 per share	3.70
SKYA SkyAI, Inc. Common Stock	$200K	277.20	N/A	N/A	$9.12 per share	0.14

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNXU Conexeu Sciences	N/A	-$0.11	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EMBC Embecta	$95.40M	$1.90	1.92	2.08	N/A	10.73%	-23.96%	14.12%	8/7/2026 (Estimated)
INFU InfuSystem	$870K	$0.38	152.36	29.48	N/A	1.12%	2.78%	1.41%	N/A
SKYA SkyAI, Inc. Common Stock	-$282.50M	-$1.63	N/A	N/A	N/A	N/A	-157.91%	-154.40%	9/2/2026 (Estimated)

Latest SKYA, CNXU, EMBC, and INFU Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2026	Q3 2026	EMBC Embecta	$0.26	N/A	N/A	N/A	$254.53 million	N/A
6/15/2026	Q2 2026	CNXU Conexeu Sciences	N/A	-$0.11	N/A	-$0.11	N/A	N/A
5/14/2026	Q1 2026	SKYA SkyAI, Inc. Common Stock	N/A	-$1.19	N/A	-$1.19	N/A	$0.19 million
5/5/2026	Q2 2026	EMBC Embecta	$0.42	$0.27	-$0.15	-$0.07	$235.67 million	$221.80 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
EMBC Embecta	$0.04	1.10%	N/A	2.11%	N/A
INFU InfuSystem	N/A	N/A	N/A	N/A	N/A
SKYA SkyAI, Inc. Common Stock	N/A	N/A	N/A	N/A	N/A

Latest SKYA, CNXU, EMBC, and INFU Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/1/2026	EMBC Embecta	quarterly	$0.01	1.2%	5/28/2026	5/28/2026	6/15/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNXU Conexeu Sciences	N/A	N/A	N/A
EMBC Embecta	N/A	2.46	1.68
INFU InfuSystem	0.50	1.98	1.59
SKYA SkyAI, Inc. Common Stock	N/A	8.28	8.08

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CNXU Conexeu Sciences	N/A
EMBC Embecta	93.83%
INFU InfuSystem	71.13%
SKYA SkyAI, Inc. Common Stock	17.17%

Insider Ownership

Company	Insider Ownership
CNXU Conexeu Sciences	N/A
EMBC Embecta	1.30%
INFU InfuSystem	10.80%
SKYA SkyAI, Inc. Common Stock	20.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CNXU Conexeu Sciences	4	26.76 million	N/A	N/A
EMBC Embecta	1,850	59.33 million	58.56 million	Optionable
INFU InfuSystem	410	20.18 million	19.10 million	Optionable
SKYA SkyAI, Inc. Common Stock	55	42.32 million	33.86 million	Not Optionable

SKYA, CNXU, EMBC, and INFU Headlines

Recent News About These Companies

Short Interest in SkyAI, Inc. Common Stock (NASDAQ:SKYA) Rises By 112.5%

July 28 at 1:39 PM | marketbeat.com

Saba Capital Management L.P. Has $2.54 Million Stock Holdings in SkyAI, Inc. Common Stock $SKYA

July 28 at 5:59 AM | marketbeat.com

SkyAI, Inc. Common Stock (NASDAQ:SKYA) Sees Large Decrease in Short Interest

July 17, 2026 | marketbeat.com

SkyAI, Inc.: SkyAI Confirms Receipt of Unsolicited, Non-Binding Proposal from Forward Industries

June 16, 2026 | finanznachrichten.de

UPDATED: Forward Industries Announces Letter of Intent to Acquire SkyAI, Inc. (SKYA)

June 15, 2026 | globenewswire.com

SkyAI receives unsolicited all-stock merger proposal from Forward Industries

June 15, 2026 | msn.com

SkyAI Confirms Receipt of Unsolicited, Non-Binding Proposal from Forward Industries

June 15, 2026 | globenewswire.com

Forward Industries Announces Letter of Intent to Acquire SkyAI, Inc. (SKYA)

June 15, 2026 | globenewswire.com

SkyAI Inc.

June 12, 2026 | money.usnews.com

Sharps Technology Appoints Arthur Levine as Chief Financial Officer

May 29, 2026 | tipranks.com

Sharps Technology Becomes SkyAI, Inc. with New Ticker Symbol “SKYA”; Establishing Category-defining Agentic Finance Platform Serving Global South

May 28, 2026 | markets.businessinsider.com

Sharps Technology Inc: Sharps Technology Reports Continued Growth in Q1 2026 Highlighting Strengthened Balance Sheet and Strong Treasury Execution

May 16, 2026 | finanznachrichten.de

Sharps Technology Reports Continued Growth in Q1 2026 Highlighting Strengthened Balance Sheet and Strong Treasury Execution

May 15, 2026 | prnewswire.com

Sharps Technology Inc: Sharps Technology Adopts Limited Duration Stockholder Rights Plan

May 15, 2026 | finanznachrichten.de

Sharps Technology Adopts Limited Duration Stockholder Rights Plan

May 14, 2026 | prnewswire.com

Sharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury Strategy

April 7, 2026 | theglobeandmail.com

Sharps Technology, Inc. Reports Financial Results for 2025 with Over 2 Million SOL and Expanded Partnerships in the Solana Ecosystem

April 6, 2026 | quiverquant.comQ

Sharps Technology and The Tie Announce Strategic Collaboration to Advance Institutional Participation in the Solana Ecosystem

February 25, 2026 | markets.businessinsider.com

Sharps Technology Appoints Interim Chief Financial Officer Levine

February 23, 2026 | tipranks.com

Holdings Ltd Falconx Sells 239,588 Shares of Sharps Technology (NASDAQ:STSS) Stock

February 14, 2026 | insidertrades.com

Sharps Technology and BitGo Announce Collaboration to Advance Solana Treasury Strategy

February 5, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKYA, CNXU, EMBC, and INFU Company Descriptions

Conexeu Sciences NASDAQ:CNXU

$8.31 -0.52 (-5.89%)

Closing price 04:00 PM Eastern

Extended Trading

$8.70 +0.39 (+4.68%)

As of 04:58 PM Eastern

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. --- Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property ("IP") developed over more than a decade at the University of British Columbia (the "University") and the BC Professional Firefighters Burn and Wound Healing Laboratory. In November 2023, the Company entered into a patent assignment agreement with the University pursuant to which the Company acquired an assignment of the University's right, title, and interest in the applicable patents and patent applications related to the underlying technology. The Company's only device candidate is the CXU™ scaffold device candidate, which is in preclinical development and has not been approved or cleared for marketing in any jurisdiction. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound care and other medical applications. Any potential benefits to patients, providers, or healthcare systems have not been established and will require further study and regulatory review. CXU™ is a temperature-responsive, collagen-based extracellular matrix ("ECM") formulation designed to transition from a liquid to a gel-like scaffold following topical application or injection, typically within approximately ten minutes (the "10 Minute Tissue™" concept). The device IP is protected by issued and pending patents and is being evaluated in preclinical studies for its ability to provide an ECM-like environment associated with cellular infiltration, vascularization, and organized tissue remodeling in non-clinical models. We intend to seek U.S. Food and Drug Administration ("FDA") clearance in the United States for the CXU™ scaffold device candidate through the 510(k) premarket notification process as a Class II medical device; however, the FDA has not yet determined the appropriate classification or regulatory pathway for our device candidate, may require additional data or a different pathway, and there can be no assurance that we will obtain clearance or that the device candidate will become commercially available. Our principal executive offices are located in Reno, Nevada.

Embecta NASDAQ:EMBC

$3.64 -0.02 (-0.55%)

Closing price 04:00 PM Eastern

Extended Trading

$3.60 -0.04 (-1.24%)

As of 04:20 PM Eastern

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

InfuSystem NYSE:INFU

$9.14 -0.05 (-0.54%)

Closing price 04:00 PM Eastern

Extended Trading

$9.14 -0.01 (-0.05%)

As of 04:10 PM Eastern

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

SkyAI, Inc. Common Stock NASDAQ:SKYA

$1.31 -0.03 (-2.24%)

As of 04:00 PM Eastern

SkyAI Inc is developing financial technology platforms focused on users in emerging markets. Its operations include the use of stablecoin-based payment infrastructure and artificial intelligence (AI) technologies to provide financial access, educational tools, and data analysis services for users in Asia, Latin America, and Africa. The company's platform will utilize the Solana blockchain network to support digital asset and on-chain data applications.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SKYA, CNXU, EMBC, and INFU Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SKYA, CNXU, EMBC, and INFU Earnings

Compare Dividends

Latest SKYA, CNXU, EMBC, and INFU Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SKYA, CNXU, EMBC, and INFU Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKYA, CNXU, EMBC, and INFU Company Descriptions

Conexeu Sciences NASDAQ:CNXU

Embecta NASDAQ:EMBC

InfuSystem NYSE:INFU

SkyAI, Inc. Common Stock NASDAQ:SKYA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SKYA, CNXU, EMBC, and INFU Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SKYA, CNXU, EMBC, and INFU Earnings

Compare Dividends

Latest SKYA, CNXU, EMBC, and INFU Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SKYA, CNXU, EMBC, and INFU Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKYA, CNXU, EMBC, and INFU Company Descriptions

Conexeu Sciences NASDAQ:CNXU

Embecta NASDAQ:EMBC

InfuSystem NYSE:INFU

SkyAI, Inc. Common Stock NASDAQ:SKYA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools